Neurotech International Limited [ASX:NTI] share price and news 2022

Company Description

Neurotech International Limited (NTI) is a medical device and solutions company whose primary mission is to improve the lives of people with neurological conditions. NTI operates in one segment being Medical Device Development and Distribution. The Company incorporated in Australia, operating through its wholly-Owned, malta-based subsidiary, AAT Research Limited.

Neurotech International Limited belongs to Health Care sector and under industry of Health Care Equipment. You can get more information about this company via their website: http://www.neurotechinternational.com.

This a small cap company with market cap of 36 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while Company PB is less than both sector and market. On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0 0 -21.3 0
Market 0.85 22.3 1.99 0.84
Sector 1.29 25.9 4.23 1.53

Dividend Growth Chart

The following chart shows you how nti dividend grows in the recent years.

No data